Abstract
Background
Nephrotic syndrome (NS) results in hypercoagulability and increased risk of infection. Furthermore, infection increases the risk of venous thromboembolism (VTE). Our objective was to determine the prevalence of infection, VTE, and the associated outcomes among a cohort of hospitalized children with NS.
Methods
All children with NS admitted to 17 pediatric hospitals across North America from 2010 to 2012 were included. Prevalence of infection and VTE was determined. Wilcoxon rank-sum and logistic regression were performed.
Results
Seven-hundred thirty hospitalizations occurred among 370 children with NS. One-hundred forty-eight children (40%) had ≥ 1 infection (211 episodes) and 11 (3%) had VTE. Those with VTE had infection more frequently (p = 0.046) and were younger at NS diagnosis (3.0 vs. 4.0 years; p = 0.008). The most common infectious pathogen identified was Streptococcus pneumoniae. The median hospital length of stay for those with infection [10 vs 5 days (p < 0.0001)] or VTE [22 vs 6 days (p < 0.0001)] was longer than those without either complication. Of those with infection, 13% had an intensive care unit (ICU) stay compared with 3.3% of those without infection. Median ICU stay was 4 days in those with VTE compared to 0 days in those without (p < 0.001). By logistic regression, only the number of ICU days was associated with VTE (OR 1.074, 95% CI 1.013–1.138).
Conclusions
Hospitalized children with NS have high rates of infection. Presence of VTE was associated with infection. Both were associated with longer hospitalizations and ICU stays.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rheault MN, Wei CC, Hains DS, Wang W, Kerlin BA, Smoyer WE (2014) Increasing frequency of acute kidney injury amongst children hospitalized with nephrotic syndrome. Pediatr Nephrol 29:139–147
Gipson DS, Messer KL, Tran CL, Herreshoff EG, Samuel JP, Massengill SF, Song P, Selewski DT (2013) Inpatient health care utilization in the United States among children, adolescents, and young adults with nephrotic syndrome. Am J Kidney Dis 61:910–917
McCaffrey J, Lennon R, Webb NJ (2016) The non-immunosuppressive management of childhood nephrotic syndrome. Pediatr Nephrol 31:1383–1402
Kerlin BA, Haworth K, Smoyer WE (2014) Venous thromboembolism in pediatric nephrotic syndrome. Pediatr Nephrol 29:989–997
Schlegel N (1997) Thromboembolic risks and complications in nephrotic children. Semin Thromb Hemost 23:271–280
Eneman B, Freson K, van den Heuvel L, van Hoyweghen E, Collard L, Vande Walle J, van Geet C, Levtchenko E (2015) Pituitary adenylate cyclase-activating polypeptide deficiency associated with increased platelet count and aggregability in nephrotic syndrome. J Thromb Haemost 13:755–767
Eneman B, Levtchenko E, van den Heuvel B, Van Geet C, Freson K (2016) Platelet abnormalities in nephrotic syndrome. Pediatr Nephrol 31:1267–1279
Loscalzo J (2013) Venous thrombosis in the nephrotic syndrome. N Engl J Med 368:956–958
Kerlin BA, Blatt NB, Fuh B, Zhao S, Lehman A, Blanchong C, Mahan JD, Smoyer WE (2009) Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study. J Pediatr 155:105–110 110 e101
Lilova MI, Velkovski IG, Topalov IB (2000) Thromboembolic complications in children with nephrotic syndrome in Bulgaria (1974-1996). Pediatr Nephrol 15:74–78
Matsell DG, Wyatt RJ (1993) The role of I and B in peritonitis associated with the nephrotic syndrome of childhood. Pediatr Res 34:84–88
McLean RH, Forsgren A, Bjorksten B, Kim Y, Quie PG, Michael AF (1977) Decreased serum factor B concentration associated with decreased opsonization of Escherichia coli in the idiopathic nephrotic syndrome. Pediatr Res 11:910–916
Anderson DC, York TL, Rose G, Smith CW (1979) Assessment of serum factor B, serum opsonins, granulocyte chemotaxis, and infection in nephrotic syndrome of children. J Infect Dis 140:1–11
Tain YL, Lin G, Cher TW (1999) Microbiological spectrum of septicemia and peritonitis in nephrotic children. Pediatr Nephrol 13:835–837
Haddy RI, Perry K, Chacko CE, Helton WB, Bowling MG, Looney SW, Buck GE (2005) Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine. Pediatr Infect Dis J 24:320–323
Crary SE, Buchanan GR, Drake CE, Journeycake JM (2006) Venous thrombosis and thromboembolism in children with osteomyelitis. J Pediatr 149:537–541
Bouchoucha S, Benghachame F, Trifa M, Saied W, Douira W, Nessib MN, Ghachem MB (2010) Deep venous thrombosis associated with acute hematogenous osteomyelitis in children. Orthop Traumatol Surg Res 96:890–893
Rheault MN, Zhang L, Selewski DT, Kallash M, Tran CL, Seamon M, Katsoufis C, Ashoor I, Hernandez J, Supe-Markovina K, D’Alessandri-Silva C, DeJesus-Gonzalez N, Vasylyeva TL, Formeck C, Woll C, Gbadegesin R, Geier P, Devarajan P, Carpenter SL, Kerlin BA, Smoyer WE, Midwest Pediatric Nephrology Consortium (2015) AKI in children hospitalized with nephrotic syndrome. Clin J Am Soc Nephrol 10:2110–2118
Robinson CL, Romero JR, Kempe A, Pellegrini C, Advisory Committee on Immunization Practices Child/Adolescent Immunization Work G (2017) Advisory committee on immunization practices recommended immunization schedule for children and adolescents aged 18 years or younger - United States, 2017. MMWR Morb Mortal Wkly Rep 66:134–135
Greenbaum LA, Benndorf R, Smoyer WE (2012) Childhood nephrotic syndrome--current and future therapies. Nat Rev Nephrol 8:445–458
Kerlin BA, Smoyer WE, Tsai J, Boulet SL (2015) Healthcare burden of venous thromboembolism in childhood chronic renal diseases. Pediatr Nephrol 30:829–837
Date K, Ettelaie C, Maraveyas A (2017) Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer. J Thromb Haemost 15:2289–2299
Long AT, Kenne E, Jung R, Fuchs TA, Renne T (2016) Contact system revisited: an interface between inflammation, coagulation, and innate immunity. J Thromb Haemost 14:427–437
Kimball AS, Obi AT, Diaz JA, Henke PK (2016) The emerging role of NETs in venous thrombosis and immunothrombosis. Front Immunol 7:236
Martinez-Aguilar G, Avalos-Mishaan A, Hulten K, Hammerman W, Mason EO Jr, Kaplan SL (2004) Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 23:701–706
Carpenter SL, Goldman JL, Sherman AK, Bell JJ, Selvaraju S, Selvarangan R (2012) Staphylococcus aureus virulence factors surface-associated adhesion (sdrD) and fibronectin-binding protein B (fnbB) associated with deep-vein thrombosis in pediatric patients. Am J Hematol 87:S147
Mahajerin A, Branchford BR, Amankwah EK, Raffini L, Chalmers E, van Ommen CH, Goldenberg NA (2015) Hospital-associated venous thromboembolism in pediatrics: a systematic review and meta-analysis of risk factors and risk-assessment models. Haematologica 100:1045–1050
Zhang LJ, Zhang Z, Li SJ, Meinel FG, Nance JW Jr, Zhou CS, Zhao YE, Schoepf UJ, Lu GM (2014) Pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome: prospective evaluation of prevalence and risk factors with CT. Radiology 273:897–906
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The Institutional Review Board at each institution approved the study.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Carpenter, S.L., Goldman, J., Sherman, A.K. et al. Association of infections and venous thromboembolism in hospitalized children with nephrotic syndrome. Pediatr Nephrol 34, 261–267 (2019). https://doi.org/10.1007/s00467-018-4072-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-018-4072-6